Evidence map›Paper›PMID 40926501›Full record

ArticleInternational journal of cancer2026

Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons.

E Lin, Hans Garmo, Kerri Beckmann, Ola Bratt, Olof Akre, Pär Stattin, Rolf Gedeborg

Abstract read
In one paragraph

Article in International journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

E LinDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0002-1710-1866
Hans GarmoDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Kerri BeckmannCancer Epidemiology and Population Health Research Group, Allied Health and Human Performance, University of South Australia, Adelaide, Australia.ORCID https://orcid.org/0000-0002-9798-1479
Ola BrattDepartment of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Olof AkreDepartment of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
Pär StattinDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Rolf GedeborgDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0002-8850-7863

Funding

Cancerfonden 19 00 30Region UppsalaUppsala UniversitetVetenskapsrådet 2022-00544
6 · The paper itself

Abstract

A family history of prostate cancer in first-degree relatives is an established risk factor for prostate cancer, but the specific associations between prostate cancer characteristics in fathers and the risk of high-risk prostate cancer in their sons remain unclear. We identified men in Prostate Cancer data Base Sweden whose fathers had been diagnosed with prostate cancer in 1998-2005. We compared the observed number of prostate cancer diagnoses in these men with the expected number in the Swedish male population, estimating standardized incidence ratios (SIR). The median age of the 25,287 included sons of men with prostate cancer was 52 years (interquartile range 47-57 years) at end of follow-up. Their overall risk of a prostate cancer diagnosis was higher if the father had been diagnosed at less than 65 years old (SIR, 4.3, 95% confidence interval [CI], 3.8-5.0), compared with having a father diagnosed when 70 years old or older (SIR, 2.3; 95% CI 1.9-2.8). Sons of fathers diagnosed at less than 65 had a higher risk of Gleason score ≥8 cancers (SIR, 2.3; 95% CI 1.1-4.1) than sons of fathers diagnosed at 70 years old or older (SIR, 1.2; 95% CI 0.4-2.6). Having a father with a Gleason ≥8 cancer was associated with an increased risk for a Gleason ≥8 cancer (SIR, 2.6; 95% CI 1.1-5.1). These population-based results suggest that the father's prostate cancer characteristics should be considered when counseling men on prostate-specific antigen testing and diagnostic strategies.

Indexed as

FathersProstatic NeoplasmsAdultAgedAge of OnsetGenetic Predisposition to DiseaseHumansIncidenceMaleMiddle AgedNeoplasm GradingRisk FactorsSwedencancer characteristicscohort studyfamily historymortalityprostate cancer

Identifiers

PMID40926501
PMCPMC12712353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.